1Ke PY,Hu CM,Chang YC,et al.Hiding human thymidine kinase 1 from APC/C-mediated destruction by thymidine binding[J].FASEB J,2007,21(4):1276-1284.
2Pérez-Pérez MJ,Priego EM,Hernández AI,et al.Structure,physiological role,and specific inhibitors of human thymidine kinase 2 (TK2):present and future[J],Med Res Rev,2008,28(5):797-820.
3Zhang J,Jia Q,Zou S,et al.Thymidine kinase 1:a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients[J].Oncol Rep,2006,15(2):455-461.
4Chabes A,Thelander L.DNA building blocks at the foundation of better survival[J].Cell Cycle,2003,2 (3):171-173.
6Munch-Petersen B.Reversible tetramerization of human TK1 to the high catalytic efficient form is induced by pyrophosphate,in addition to tripolyphosphates,or high enzyme concentration[J].FEBS J,2009,276(2):571-580.
8Welin M,Kosinska U,Mikkelsen NE,et al.Structures of thymidine kinase 1 of human and mycoplasmic origin[J].Proc Natl Acad Sci U S A,2004,101(52):17970-17975.
9Mao Y,Wu J,Wang N,et al.A comparative study:immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer[J].Cancer Invest,2002,20 (7-8):922-931.
10He Q,Zou L,Zhang PA,et al.The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody[J].Int J Biol Markers,2000,15 (2):139-146.
7Brot P, Romain S, Daver A, et al. Thymidine kinase as a proliferative marker: clinical relevance in 1692 primary breast cancer patients [ J ]. J Clin Oncol, 2001,19 : 2778- 2787.
9Ke PY, Chang ZF. Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/ cyclosome-CDHl-mediated pathway [ J ]. Mol Cell Biol,2004,24 : 514-526.
10Wu C J, Yang RJ,Zhou J,et al. Production and characterisation of a novel chicken IgY antibody raised against Cterminal peptide from human thymidine kinase 1 [ J ]. Immunol Methods,2003,277 : 157-169.
